Silicone breast implant access by reconstruction patients to be improved -- FDA petition response.
This article was originally published in The Gray Sheet
SILICONE BREAST IMPLANT ACCESS TO BE IMPROVED FOR RECONSTRUCTION PATIENTS, FDA says in an Oct. 15 response to a citizen's petition. In the response, signed by FDA Lead Deputy Commissioner Michael Friedman, the agency says that although it still does not have enough data to lift current restrictions on silicone breast implant availability, it will take specific steps to ensure that breast reconstruction patients have access to the products. The petition, submitted in September 1996 by the Y-ME National Breast Cancer Organization, sought broader availability of the implants.
You may also be interested in...
The director of adult immunizations at Johns Hopkins International Vaccine Access Center talks to Scrip about undertaking a massive COVID-19 vaccination effort in the US.
P&G’s oral care business drove 35% of total category market growth in the firm’s fiscal 2020 and exemplifies its growth strategy for all segments – grow entire categories rather than take competitors’ market share, says CFO Jon Moeller.
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.